Atea Pharmaceuticals Inc

The current institutional shareholding score of Atea Pharmaceuticals Inc is 7.00, ranking 81 out of 389 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 70.93%, representing a quarter-over-quarter decrease of 6.88%. The largest institutional shareholder is James Simons, holding a total of 0.00 shares, representing 1.46% of shares outstanding, with 0.17% increase in holdings.